1. Akaza H, Isaka S, Koiso K, Kotake T, Machida T, Maru A, Matsumura Y, Niijima T, Obata K, Ohe H, Ohi Y, Shimazaki J, Tashiro K, Ueda T, Uyama T, the Japanese Urological Cancer Research Group for Adriamycin (1987) Comparative analysis of short-term and longterm prophylactic intravesical chemotherapy of superficial bladder cancer. Prospective, randomized, controlled studies of the Japanese Urological Cancer Research Group. Cancer Chemother Pharmacol 20[Suppl]:S91
2. Babaya K, Takahashi S, Momose H, Matsuki H, Sasaki K, Samma S, Ozono S, Hirao Y, Okajima E (1987) Effect of single chemotherapeutic agents on development of urinary bladder tumors induced byN-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN) in rats. Urol Res 15:329
3. Hirao Y, Okajima E, Ohara S, Ozono S, Hiramatsu T, Yoshida K, Yamada K, Aoyama H, Hashimoto M, Watanabe S (1987) Prophylactic treatment for superficial bladder cancer following transurethral resection. Cancer Chemother Pharmacol 20 [Suppl]:S85
4. Ichikawa T, Japan Research Group of Bladder Carcinoma (1972) Clinical application of 2,5-di-O-acetyl-?-d-glucaro(1?4)-(6?3)-dilactone (SLA) to bladder tumors, with special reference to its effect on the frequency of tumor recurrence. J Urol 108:571
5. Jones HC, Swinney J (1961) Thio-TEPA in the treatment of tumors of the bladder. Lancet II:615